MedPath

Evaluation of Programs of Reeducation for Urinary Incontinence in Woman

Not Applicable
Terminated
Conditions
Urinary Incontinence
Registration Number
NCT02899520
Lead Sponsor
Hopital Foch
Brief Summary

The objective of this study is to compare two methods of pelvic floor muscle training: reference method versus CMP ® method ( (Connaissance et Maîtrise de Périnée : Knowledge and Control of Perineum)

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Patients more than 18 years old and less than 75 years
  • Patients presenting an urinary incontinence of effort or mixed symptomatic associated with a pelvic statics disorder
  • Patients with a perineale reeducation prescription
  • Patients affiliated to a national insurance scheme or benefiting from such a program
  • Patients having given her written consent form
Exclusion Criteria
  • Nulliparous woman
  • Patients already operated for their incontinence
  • Patients with a prolapse of higher level at the stage II of the classification POP-Q (Pelvic Organ Prolapse Quantification)
  • Pregnant women
  • Patients presenting an associated anal incontinence,
  • Patients presenting a cancellation (section of marrow, syringomyelia for example) or an inversion of perineum control
  • Patients having given birth less than 6 months before the care
  • Patients having benefited from a pelvi-périnéale reeducation in the previous 12 months,
  • Patients presenting psychiatric disease
  • Patients presenting a vaginismus,
  • Patients presenting a contraindication to the practice of the electrostimulation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
USP (Urinary Symptoms Profile) score38 weeks

Urinary Symptoms Profile score

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hopital Foch

🇫🇷

Suresnes, France

Hopital Foch
🇫🇷Suresnes, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.